Vertex Pharmaceuticals, Inc. (VRTX)
442.08
+0.72
(+0.16%)
USD |
NASDAQ |
Jan 20, 16:00
440.04
-2.04
(-0.46%)
Pre-Market: 08:05
Vertex Pharmaceuticals Total Liabilities (Quarterly): 7.544B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Amgen, Inc. | 80.52B |
| Eli Lilly & Co. | 91.08B |
| Merck & Co., Inc. | 77.64B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.86B |
| Shareholders Equity (Quarterly) | 17.32B |
| Debt to Equity Ratio | 0.1059 |
| Current Ratio | 2.362 |
| Net Debt Paydown Yield | -0.18% |